IONIS-STAT3Rx

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IONIS-STAT3Rx, covering 2018-06-25 to 2018-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers [Phase 1, Phase 2]

See pricing